Frequent methylation of p16INK4A and p14ARF genes implicated in the evolution of chronic myeloid leukaemia from its chronic to accelerated phase

被引:31
作者
Nagy, E
Beck, Z
Kiss, A
Csoma, E
Telek, B
Kónya, J
Oláh, É
Rák, K
Tóth, FD
机构
[1] Univ Debrecen, Med & Hlth Sci Ctr, Inst Med Microbiol, H-4012 Debrecen, Hungary
[2] Univ Debrecen, Med & Hlth Sci Ctr, Dept Med 2, H-4012 Debrecen, Hungary
[3] Univ Debrecen, Med & Hlth Sci Ctr, Dept Pediat, H-4012 Debrecen, Hungary
关键词
chronic myeloid leukaemia; acceleration; p16(INK4A); p14(ARF); promoter methylation;
D O I
10.1016/S0959-8049(03)00552-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The frequency and mechanism of p16(INK4A) and p(14ARF) gene alterations were Studied in cell samples from 30 patients with Philadelphia (Ph) chromosome-positive chronic myeloid leukaemia (CML), both at diagnosis and at the onset of the accelerated phase (AP) of the disease. No alterations in the p16(INK4A) or p(14ARF) genes were found in any of the chronic phase (CP) samples. DNA sequencing analyses detected p16(INK4A) or p(14ARF) mutations in 17 AP samples. All mutations were heterozygous without loss of the other allele. Aberrant methylation of the p16(INK4A) or p14(ARF) promoters was found in 14 of 30 AP samples. The most common situation was the simultaneous methylation of both promoters. Our data indicate that p16(INK4A) and p14(ARF) are primary targets for inactivation by promoter methylation in the acceleration of CML. Transcriptional silencing of the p16(INK4A) and p14(ARF) genes may be important in the conversion of CML from the CP to the AP. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2298 / 2305
页数:8
相关论文
共 30 条
[1]   Frequent methylation silencing of p15INK4b (MTS2) and p16INK4a (MTS1) in B-cell and T-cell lymphomas [J].
Baur, AS ;
Shaw, P ;
Burri, N ;
Delacrétaz, F ;
Bosman, FT ;
Chaubert, P .
BLOOD, 1999, 94 (05) :1773-1781
[2]   Changes in oncogene expression implicated in evolution of chronic granulocytic leukemia from its chronic phase to acceleration [J].
Beck, Z ;
Bácsi, A ;
Kovács, E ;
Kiss, J ;
Kiss, A ;
Balogh, E ;
Telek, B ;
Tóth, FD ;
Andirkó, I ;
Oláh, E ;
Udvardy, M ;
Rak, K .
LEUKEMIA & LYMPHOMA, 1998, 30 (3-4) :293-306
[3]   Alterations of P53 and RB genes and the evolution of the accelerated phase of chronic myeloid leukemia [J].
Beck, Z ;
Kiss, A ;
Tóth, FD ;
Szabó, J ;
Bácsi, A ;
Balogh, E ;
Borbély, A ;
Telek, B ;
Kovács, E ;
Oláh, É ;
Rak, K .
LEUKEMIA & LYMPHOMA, 2000, 38 (5-6) :587-597
[4]   FREQUENT SOMATIC MUTATIONS AND HOMOZYGOUS DELETIONS OF THE P16 (MTS1) GENE IN PANCREATIC ADENOCARCINOMA [J].
CALDAS, C ;
HAHN, SA ;
DACOSTA, LT ;
REDSTON, MS ;
SCHUTTE, M ;
SEYMOUR, AB ;
WEINSTEIN, CL ;
HRUBAN, RH ;
YEO, CJ ;
KERN, SE .
NATURE GENETICS, 1994, 8 (01) :27-32
[5]  
Chen TC, 2000, ANTICANCER RES, V20, P1621
[6]  
Esteller M, 2001, CANCER RES, V61, P2816
[7]  
Esteller M, 2000, CANCER RES, V60, P129
[8]   Genomic alterations of the p19ARF encoding exons in T-cell acute lymphoblastic leukemia [J].
Gardie, B ;
Cayuela, JM ;
Martini, S ;
Sigaux, F .
BLOOD, 1998, 91 (03) :1016-1020
[9]  
Güran S, 1998, HAEMATOLOGIA, V29, P181
[10]   P16(INK4A) AND P15(INK4B) GENE DELETIONS IN PRIMARY LEUKEMIAS [J].
HAIDAR, MA ;
CAO, XB ;
MANSHOURI, T ;
CHAN, LL ;
GLASSMAN, A ;
KANTARJIAN, HM ;
KEATING, MJ ;
BERAN, MS ;
ALBITAR, M .
BLOOD, 1995, 86 (01) :311-315